Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2131.2 4
0116-0413
532.50 414.86 753 104.47 0.867
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 256.0 4
0117-0413
233.92 412.73 412 77.26 0.867
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 275.1 4
0118-0411
359.40 410.70 415 78.08 0.855
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 922.9 4
0119-0413
630.06 411.74 381 77.64 0.794
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 490.8 4
0120-0419
285.91 418.45 839 108.81 0.890
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 310.3 4
0121-0421
695.14 420.42 479 90.81 0.730
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 467.2 4
0122-0419
436.31 419.40 407 76.08 0.884
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1452.2 4
0123-0425
110.14 425.64 562 94.81 0.786
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 697.7 4
0124-0426
645.96 426.73 455 80.57 0.881
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 350.8 4
0125-0425
866.84 425.04 392 76.91 0.833
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 249.3 4
0126-0426
382.97 426.70 214 60.77 0.728
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 327.5 4
0127-0431
777.43 430.82 454 83.15 0.825
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 328.7 4
0128-0436
705.74 437.07 413 81.98 0.772
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 749.6 4
0129-0435
319.58 435.80 410 76.08 0.890
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 363.6 4
0130-0446
599.20 446.02 744 100.81 0.920
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 395.7 4
0131-0448
163.99 448.51 430 78.08 0.886
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 430.5 4
0132-0456
276.89 456.42 424 78.08 0.874
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 355.4 4
0133-0459
905.75 457.52 380 75.98 0.827
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 385.1 4
0134-0468
888.60 469.74 418 79.74 0.826
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3668.1 4
0135-0474
695.70 474.53 764 106.23 0.851
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 535.3 4
0136-0477
370.65 476.79 426 80.81 0.820
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 514.8 4
0137-0481
112.68 481.24 401 78.33 0.821
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 351.0 4
0138-0488
213.74 488.34 406 78.67 0.824
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 270.7 4
0139-0486
603.59 485.86 424 78.91 0.856
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 309.3 4
0140-0492
76.49 492.01 442 82.33 0.820